Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration

Lancet. 2024 Mar 23;403(10432):1110-1111. doi: 10.1016/S0140-6736(24)00229-0. Epub 2024 Mar 7.

Author

Affiliation

¹ Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD 20892-1204, USA. Electronic address: echew@nei.nih.gov.

PMID: 38461839
DOI: 10.1016/S0140-6736(24)00229-0

No abstract available

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Humans
Macular Degeneration* / drug therapy
Ranibizumab / therapeutic use
Retrospective Studies
Tomography, Optical Coherence
Wet Macular Degeneration* / drug therapy

Substances

Angiogenesis Inhibitors
Ranibizumab